Cargando…
Guillain-Barre Syndrome following COVID-19 Infection: First Case Report from Kuwait and Review of the Literature
OBJECTIVE: Guillain-Barré syndrome (GBS) is an acute immune-mediated polyradiculoneuropathy that is often related to a previous infectious exposure. GBS emerged as a potentially serious complication of coronavirus disease 2019 (COVID-19) since its declaration as a global pandemic. We report the firs...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
S. Karger AG
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8089421/ http://dx.doi.org/10.1159/000513382 |
_version_ | 1783687040574947328 |
---|---|
author | Kamel, Walaa A. Ibrahim Ismail, Ismail Al-Hashel, Jasem Yousef |
author_facet | Kamel, Walaa A. Ibrahim Ismail, Ismail Al-Hashel, Jasem Yousef |
author_sort | Kamel, Walaa A. |
collection | PubMed |
description | OBJECTIVE: Guillain-Barré syndrome (GBS) is an acute immune-mediated polyradiculoneuropathy that is often related to a previous infectious exposure. GBS emerged as a potentially serious complication of coronavirus disease 2019 (COVID-19) since its declaration as a global pandemic. We report the first case from Kuwait, to the best of our knowledge. CLINICAL PRESENTATION: A 72-year-old male presented with 3 weeks history of acute progressive and ascending lower limbs weakness. He developed these symptoms 3 weeks after testing positive to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Electrophysiological studies showed acute demyelinating polyradiculoneuropathy and cerebrospinal fluid showed protein-cell dissociation. He was successfully treated with intravenous immunoglobulins (IVIGs). CONCLUSION: Neurologists should be aware of GBS as a potentially serious complication associated with COVID-19. Our patient had a favorable outcome with IVIG with no autonomic or respiratory affection. |
format | Online Article Text |
id | pubmed-8089421 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | S. Karger AG |
record_format | MEDLINE/PubMed |
spelling | pubmed-80894212021-05-03 Guillain-Barre Syndrome following COVID-19 Infection: First Case Report from Kuwait and Review of the Literature Kamel, Walaa A. Ibrahim Ismail, Ismail Al-Hashel, Jasem Yousef Dubai Medical Journal Case Report OBJECTIVE: Guillain-Barré syndrome (GBS) is an acute immune-mediated polyradiculoneuropathy that is often related to a previous infectious exposure. GBS emerged as a potentially serious complication of coronavirus disease 2019 (COVID-19) since its declaration as a global pandemic. We report the first case from Kuwait, to the best of our knowledge. CLINICAL PRESENTATION: A 72-year-old male presented with 3 weeks history of acute progressive and ascending lower limbs weakness. He developed these symptoms 3 weeks after testing positive to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Electrophysiological studies showed acute demyelinating polyradiculoneuropathy and cerebrospinal fluid showed protein-cell dissociation. He was successfully treated with intravenous immunoglobulins (IVIGs). CONCLUSION: Neurologists should be aware of GBS as a potentially serious complication associated with COVID-19. Our patient had a favorable outcome with IVIG with no autonomic or respiratory affection. S. Karger AG 2021-03-18 /pmc/articles/PMC8089421/ http://dx.doi.org/10.1159/000513382 Text en Copyright © 2021 by S. Karger AG, Basel https://creativecommons.org/licenses/by-nc-nd/4.0/This article is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND). Usage and distribution for commercial purposes as well as any distribution of modified material requires written permission. Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug. Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. |
spellingShingle | Case Report Kamel, Walaa A. Ibrahim Ismail, Ismail Al-Hashel, Jasem Yousef Guillain-Barre Syndrome following COVID-19 Infection: First Case Report from Kuwait and Review of the Literature |
title | Guillain-Barre Syndrome following COVID-19 Infection: First Case Report from Kuwait and Review of the Literature |
title_full | Guillain-Barre Syndrome following COVID-19 Infection: First Case Report from Kuwait and Review of the Literature |
title_fullStr | Guillain-Barre Syndrome following COVID-19 Infection: First Case Report from Kuwait and Review of the Literature |
title_full_unstemmed | Guillain-Barre Syndrome following COVID-19 Infection: First Case Report from Kuwait and Review of the Literature |
title_short | Guillain-Barre Syndrome following COVID-19 Infection: First Case Report from Kuwait and Review of the Literature |
title_sort | guillain-barre syndrome following covid-19 infection: first case report from kuwait and review of the literature |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8089421/ http://dx.doi.org/10.1159/000513382 |
work_keys_str_mv | AT kamelwalaaa guillainbarresyndromefollowingcovid19infectionfirstcasereportfromkuwaitandreviewoftheliterature AT ibrahimismailismail guillainbarresyndromefollowingcovid19infectionfirstcasereportfromkuwaitandreviewoftheliterature AT alhasheljasemyousef guillainbarresyndromefollowingcovid19infectionfirstcasereportfromkuwaitandreviewoftheliterature |